Company profile for Affimed

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Affimed was founded in 2000 based on technology developed by the group of Prof. Melvyn Little at the German Cancer Research Center (DKFZ) in Heidelberg. We are a team of passionate, experienced individuals who work every day to improve the lives of patients. Led by an expert team of biotechnology and pharmaceutical professionals, we are united by one goal—to stop cancer from ever derailing patients’ lives. Inspired by t...
Affimed was founded in 2000 based on technology developed by the group of Prof. Melvyn Little at the German Cancer Research Center (DKFZ) in Heidelberg. We are a team of passionate, experienced individuals who work every day to improve the lives of patients. Led by an expert team of biotechnology and pharmaceutical professionals, we are united by one goal—to stop cancer from ever derailing patients’ lives. Inspired by the immense potential of the innate immune system, we are dedicated to unlocking profound possibilities—bringing new hope to those whose lives have been forever changed by the impact of cancer.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Germany
Address
Address
Technologiepark Im Neuenheimer Feld 582 69120 Heidelberg
Telephone
Telephone
+49-(0)6221-65307-0
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/05/14/3080948/0/en/Affimed-Announces-Receipt-of-Nasdaq-Delisting-Notice.html

GLOBENEWSWIRE
14 May 2025
Affimed Files for Insolvency Proceedings
Affimed Files for Insolvency Proceedings

13 May 2025

// GLOBENEWSWIRE

https://www.globenewswire.com/news-release/2025/05/13/3080104/0/en/Affimed-Announces-Filing-for-the-Opening-of-Insolvency-Proceedings.html

GLOBENEWSWIRE
13 May 2025

https://www.globenewswire.com/news-release/2025/04/29/3070387/0/en/Affimed-Shows-Higher-Exposure-of-AFM24-is-Associated-with-Significantly-Higher-Response-Rates-and-Progression-Free-Survival-in-Refractory-NSCLC-Patients-at-AACR-Annual-Meeting.html

GLOBENEWSWIRE
29 Apr 2025

https://www.globenewswire.com/news-release/2025/04/23/3066553/0/en/Affimed-Announces-Acceptance-of-Three-Abstracts-for-Presentation-at-the-American-Society-for-Clinical-Oncology-Annual-Meeting.html

GLOBENEWSWIRE
23 Apr 2025

https://www.globenewswire.com/news-release/2025/04/21/3064526/0/en/Affimed-Announces-Receipt-of-NASDAQ-Deficiency-Notice-Regarding-Minimum-Bid-Price-Requirement.html

GLOBENEWSWIRE
21 Apr 2025

https://www.globenewswire.com/news-release/2025/03/25/3049178/0/en/Affimed-Announces-Acceptance-of-AFM24-Abstract-on-Dose-Optimization-for-Presentation-at-American-Association-for-Cancer-Research-Annual-Meeting.html

GLOBENEWSWIRE
25 Mar 2025

ABOUT THIS PAGE

Contact Affimed and get a quotation

Affimed is a supplier offers 1 products (APIs, Excipients or Intermediates).

Find a price of BISPECIFIC MAB ICE® TARGETING CD123 / CD16A (PRODUCT CODE: AFM28) bulk with DMF offered by Affimed

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty